Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.14 Billion | USD 23.65 Billion | 6.75% | 2023 |
The global enzymes market size was worth around USD 13.14 billion in 2023 and is predicted to grow to around USD 23.65 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.75% between 2024 and 2032.
The study includes drivers and restraints for the enzymes market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the enzymes market on a global as well as regional level.
Enzymes are biocatalysts that speed up different biochemical reactions. Enzymes are useful biocatalysts in a variety of industrial and chemical processes in the present scenario. They play an important role in chemical engineering, food technology, and farming. The use of enzymes minimizes costs, reduces production time, and improves the quality of the reaction of the substrate. Enzymes are commonly used in the detergent sector for the removal of cloth stains. In addition, they are used in a variety of processes like baking or brewing in the food and beverage industry. Moreover, enzymes are also used for drug formulation in the pharmaceutical industry.
The rising need for effective cosmetics & pharmaceutical products and surging demand for functional food & beverages are the factors driving the global enzymes market. Moreover, increasing the application of enzyme-based techniques for the detection & treatment of various chronic diseases is likely to boost the growth of enzymes market. Additionally, the increasing usage of enzymes in the food & beverage and paper & pulp industry is further expected to accelerate the enzymes market growth in the upcoming years as well.
However, the stringent government regulations in developed countries are likely to restrain the market growth in the near future. Conversely, the manufacturers of enzymes are largely focusing on research & development to enhance the functionalities of the enzyme. Thus, this is anticipated to offer lucrative opportunities to the global enzymes market during the forecast period.
The global enzymes market is classified on the basis of product type, source, reaction type, application, and end-user.
Based on the product type, segment includes polymerase & nucleases, protease, carbohydrase, lipase, and others. The carbohydrate segment dominated the global enzymes market and accounted for around 48% of the market share. The carbohydrase enzyme is widely used in the production of sugar syrup in the food processing industry.
Based on the source, the market is segmented into microorganisms, plants, and animals.
Based on the reaction type, segmentation includes hydrolase, oxidoreductase, transferase, lyase, and others. General cargo accounted for the largest market share in 2018 and is expected to register significant growth during the forecast period.
Based on the application, segmentation includes household care, pharmaceutical & biotechnology, food & beverages, bioenergy, feed, and others. The pharmaceutical segment is projected to dominate the global enzymes market owing to the growing application of enzymes in the manufacturing process of generic drugs.
Report Attributes | Report Details |
---|---|
Report Name | Enzymes Market Research Report |
Market Size in 2023 | USD 13.14 Billion |
Market Forecast in 2032 | USD 23.65 Billion |
Growth Rate | CAGR of 6.75% |
Number of Pages | 215 |
Key Companies Covered | Amano Enzyme Inc., AB Enzyme, Agilent Technologies, Novozyme A/S, BioVision Inc., ENMEX, Bioline, F. Hoffmann-La Roche AG, Fapon Biotech Inc., Lucigen, DowDuPont Inc., New England Biolabs, DNA Polymerase Technology, Inc., and Biorbyt Ltd |
Segments Covered | By Product Type, By Source, By Reaction Type, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
In 2018, North America dominated the global enzymes market. In North America, the U.S. is projected to be the dominating nation owing to the rising use of enzymes in diagnostic and pharmaceutical applications. Additionally, the manufacturers in North America are focusing on enhancing the capacity of enzyme production due to growing demands in various end-user industries.
The global enzymes market is dominated by players like:
By Product Type
By Source
By Reaction Type
By Application
By Region
FrequentlyAsked Questions
Enzymes are biological molecules, usually proteins, that serve as catalysts in living organisms. They serve an important function in accelerating chemical reactions within cells without being consumed or changed in the process.
Enzymes are commonly employed in the manufacturing of medications such as biologic drugs, antibiotics, and therapeutic proteins. The biopharmaceutical industry's growth, fueled by factors such as rising chronic illness prevalence, need for personalised medication, and biotechnology developments, drives demand for enzymes.
The global enzymes market size was worth around USD 13.14 billion in 2023 and is predicted to grow to around USD 23.65 billion by 2032.
The global enzymes market a compound annual growth rate (CAGR) of roughly 6.75% between 2024 and 2032.
In 2018, North America dominated the global enzymes market. In North America, the U.S. is projected to be the dominating nation owing to the rising use of enzymes in diagnostic and pharmaceutical applications. Additionally, the manufacturers in North America are focusing on enhancing the capacity of enzyme production due to growing demands in various end-user industries.
Some of the key players operating in the global enzymes market include Amano Enzyme Inc., AB Enzyme, Agilent Technologies, Novozyme A/S, BioVision Inc., ENMEX, Bioline, F. Hoffmann-La Roche AG, Fapon Biotech Inc., Lucigen, DowDuPont Inc., New England Biolabs, DNA Polymerase Technology, Inc., and Biorbyt Ltd., among others.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed